SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
暂无分享,去创建一个
Mark S. Anderson | J. Casanova | J. Fellay | T. Maniatis | M. Gut | L. Notarangelo | J. Franco | S. Tangye | E. Haddad | P. Soler-Palacín | A. Šedivá | Y. Lau | Q. Pan-Hammarström | M. Kaforou | M. Levin | Shen-Ying Zhang | M. Papadaki | T. Kuijpers | G. Novelli | F. Al-Mulla | G. Blanchard-Rohner | L. Abel | Y. Itan | J. Milner | L. Hammarström | S. Henrickson | E. Bellos | A. Novelli | Erica G. Schmitt | M. Butte | A. Bolze | A. Puel | G. Aytekin | G. Casari | E. Andreakos | S. Okada | K. Imai | F. Haerynck | P. Lebon | A. Belot | I. Meyts | T. Mogensen | E. Jouanguy | H. Su | A. A. Abou Tayoun | A. Aiuti | P. Brodin | R. Halwani | I. Jordan | A. Schlüter | Y. Seeleuthner | R. Colobran | P. Bastard | Jacques G. Rivière | Danyel Lee | D. van de Beek | R. Pérez de Diego | V. Sancho-Shimizu | T. Özçelik | M. Arditi | S. Keles | D. Bogunovic | D. Bonnet | O. Yeşilbaş | E. Şevketoğlu | L. Alsina | C. Rodríguez-Gallego | Y. Bryceson | C. Aytekin | Qian Zhang | E. Hsieh | S. Bando | A. Volokha | F. Bajolle | J. Herberg | Q. Philippot | H. Abolhassani | A. Cobat | Z. Orbak | S. Mahmoudi | A. Pujol | O. Kasapcopur | B. Kandemir | G. Bayhan | D. Mansouri | N. Hatipoğlu | M. Shahrooei | A. Condino-Neto | L. Hoste | C. Flores | A. Karbuz | J. Celik | C. Biggs | B. Sözeri | M. Kwan | S. Aguilera-Albesa | D. Blázquez-Gamero | A. Gagro | J. Toubiana | A. Rodríguez-Palmero | Markéta Bloomfield | B. Drolet | Juan Valencia-Ramos | C. Lucas | A. Kılıç | A. Parlakay | S. Delafontaine | E. Erdeniz | Z. G. Gayretli Aydın | A. Yahşi | K. Béland | Laura Planas-Serra | M. Emiroğlu | O. Akcan | G. Alkan | S. Aytekin | Yahya Gul | Ş. Tüter Öz | Ş. Bozdemir | S. K. Yüksek | B. Gülhan | E. Özkan | Şehnaz Aydemir | Hasan Kapaklı | V. Yarar | A. Yosunkaya | H. Vatansev | S. H. Torun | S. Nepesov | T. Coşkuner | Y. Demirkol | M. Yildiz | Adam Klocperk | Laura Marque | J. Neves | A. Bousfiha | Saleh Almuhsen | A. Sobh | Weite Lei | Peng Zhang | Majistor Maglorius | Simon J. Pelham | Stephanie Menikou | Carolina Prando | A. Cavalcanti | O. Boyarchuk | Anastasiia Bondarenko | Yuriy Stepanovskiy | Lisa Arkin | M. Cooper | S. Chakravorty | S. Keleş | A. Klocperk | Levi Hoste | M. Bloomfield | P. Soler‐Palacín | S. Yüksek | Hassan Abolhassani | Evangelos Bellos | Carlos Flores | Mehmet Yildiz | Mehmet Yıldız | Aysun Yahši | Belgin Gülhan | Mohammad Shahrooei | Osman Yeşilbaş | Agustí Rodríguez-Palmero
[1] anonymous,et al. Addition of Nonauthor Collaborator Names of the French Covid-19 Paediatric Inflammation Consortium. , 2021, JAMA.
[2] D. Hafler,et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children , 2021, Immunity.
[3] A. Ramaswamy,et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Ramaswamy et al. 2021 Supplementary Tables , 2021 .
[4] Mark S. Anderson,et al. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19 , 2021, bioRxiv.
[5] E. Wherry,et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 , 2021, Science Immunology.
[6] Hatem Al Rawahi,et al. ACUTE APPENDICITIS MIMICKING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: CASE REPORT AND REVIEW OF THE LITERATURE , 2021, Journal of paediatrics and child health.
[7] J. Casanova,et al. Superantigenic TCR Vbeta 21.3 signature in Multisystem Inflammatory Syndrome in Children , 2021, medRxiv.
[8] J. Karakaya,et al. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean , 2021, Clinical Rheumatology.
[9] S. Özcan,et al. Comparison of baseline laboratory findings of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis and multisystem inflammatory syndrome in children , 2021, International journal of rheumatic diseases.
[10] B. Pulendran,et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine , 2021, The Journal of experimental medicine.
[11] A. Belot,et al. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children. , 2021, JAMA.
[12] T. Ganzenmueller,et al. A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19 , 2021, BMC Infectious Diseases.
[13] Pedro Taffarel,et al. Multisystem inflammatory syndrome in children related to COVID-19: An update regarding the presentation of two critically ill patients. , 2021, Archivos argentinos de pediatria.
[14] M. Juan,et al. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease. , 2021, The Journal of clinical investigation.
[15] G. Ghatasheh,et al. COVID-19-Related Giant Coronary Aneurysms in an Infant with Multisystem Inflammatory Disorder in Children: The First Case Report from the United Arab Emirates and the Arab Region , 2021, Case reports in infectious diseases.
[16] Jérémie F. Cohen,et al. Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France , 2021, Journal of Clinical Immunology.
[17] Ji Hyuk Lee,et al. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children , 2020, Journal of Korean medical science.
[18] Jérémie F. Cohen,et al. Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic. , 2021, Clinical chemistry.
[19] E. Draper,et al. Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance , 2020, The Lancet Child & Adolescent Health.
[20] F. Haerynck,et al. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review , 2020, European Journal of Pediatrics.
[21] J. Trück,et al. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland , 2021, Frontiers in Pediatrics.
[22] J. Casanova,et al. Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation , 2020, Med.
[23] S. Hashimoto,et al. Time Course of Coronary Artery Aneurysms in Kawasaki Disease. , 2020, The Journal of pediatrics.
[24] E. Wherry,et al. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19) , 2020, Journal of the Pediatric Infectious Diseases Society.
[25] Jérémie F. Cohen,et al. Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[26] M. Levin,et al. Multisystem Inflammatory Syndrome in Children: An International Survey , 2020, Pediatrics.
[27] G. Blanchard-Rohner,et al. Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 , 2020, Journal of the Pediatric Infectious Diseases Society.
[28] M. H. Cheng,et al. Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome , 2020, bioRxiv.
[29] D. De Wolf,et al. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. , 2020, Circulation.
[30] M. C. Magalhães-Barbosa,et al. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study , 2020, Jornal de Pediatria.
[31] T. Cassidy-Smith,et al. Multisystem Inflammatory Syndrome in Children , 2020, The Journal of Emergency Medicine.
[32] D. Kim,et al. Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea , 2020, Journal of Korean medical science.
[33] D. Setiabudi,et al. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia , 2020, IDCases.
[34] S. Renolleau,et al. Addition of Corticosteroids to Immunoglobulins Is Associated With Recovery of Cardiac Function in Multi-Inflammatory Syndrome in Children , 2020, Circulation.
[35] Todd A. Johnson,et al. Association of an IGHV3-66 gene variant with Kawasaki disease , 2020, Journal of Human Genetics.
[36] M. Levin. Multisystem Inflammatory Syndrome in Children in the United States. Reply. , 2020, The New England journal of medicine.
[37] P. Suryawanshi,et al. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) , 2020, The Indian Journal of Pediatrics.
[38] J. Newburger,et al. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children , 2020, Journal of the American College of Cardiology.
[39] M. S. Rezai,et al. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran , 2020, BMC Pediatrics.
[40] C. Newton-Cheh,et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[41] Pallavi,et al. Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC) , 2020, The Indian Journal of Pediatrics.
[42] Ayesha Javed,et al. Kawasaki Disease-Like Features in 10 Pediatric COVID-19 Cases: A Retrospective Study , 2020, Cureus.
[43] Fadi N Busaleh,et al. Multisystem Inflammatory Syndrome in Children, the Real Disease of COVID-19 in Pediatrics - A Multicenter Case Series From Al-Ahsa, Saudi Arabia , 2020, Cureus.
[44] J. McDonagh,et al. Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) , 2020, Journal of clinical medicine.
[45] P. Ishimine,et al. Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature , 2020, The Journal of Emergency Medicine.
[46] M. H. Cheng,et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.
[47] K. Ludwikowska,et al. The first case of pediatric inflammatory multisystem syndrome (PIMS-TS) in Poland, complicated by giant coronary artery aneurysms. , 2020, Kardiologia polska.
[48] Steven M. Holland,et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.
[49] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[50] D. Hsu,et al. Cardiac Abnormalities Seen in Pediatric Patients During the SARS‐CoV2 Pandemic: An International Experience , 2020, Journal of the American Heart Association.
[51] S. Tibby,et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process , 2020, The Lancet Child & Adolescent Health.
[52] S. Patnaik,et al. Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid , 2020, The Indian Journal of Pediatrics.
[53] K. Wilson,et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.
[54] A. Tremoulet,et al. Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America. , 2020, The Pediatric infectious disease journal.
[55] R. Yeung,et al. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names , 2020, Canadian Medical Association Journal.
[56] M. M. van der Zalm,et al. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19. , 2020, The Pediatric infectious disease journal.
[57] Álvaro Freitas Moreira,et al. Multisystem inflammatory syndrome in children: A systematic review , 2020, EClinicalMedicine.
[58] J. Rossano,et al. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States , 2020, Journal of the American College of Cardiology.
[59] V. Ziaee,et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran , 2020, Epidemiology and Infection.
[60] G. Izquierdo,et al. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic , 2020, International Journal of Infectious Diseases.
[61] Sohan Seth,et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.
[62] M. C. Justino,et al. MULTISYSTEM INFLAMMATORY SYNDROME IN A CHILD ASSOCIATED WITH CORONAVIRUS DISEASE 19 IN THE BRAZILIAN AMAZON: FATAL OUTCOME IN AN INFANT , 2020, Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo.
[63] M. McCulloch,et al. Multisystem inflammatory syndrome in children in South Africa , 2020, The Lancet Child & Adolescent Health.
[64] J. R. Rebello Pinho,et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome , 2020, The Lancet Child & Adolescent Health.
[65] J. Newburger,et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. , 2020, Circulation.
[66] M. Alves,et al. Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belém, Pará, Brazil. , 2020, The Pediatric infectious disease journal.
[67] M. Malim,et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.
[68] K. Reilly,et al. COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[69] P. Bobhate,et al. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India , 2020, Indian Pediatrics.
[70] P. Agrawal,et al. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation , 2021 .
[71] N. Sultana,et al. Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan , 2020, The Lancet Child & Adolescent Health.
[72] S. Kabir,et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19 , 2020, European heart journal cardiovascular Imaging.
[73] A. Ramanan,et al. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome — Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children , 2020, Indian Pediatrics.
[74] E. Chow,et al. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review , 2020, The Journal of Pediatrics.
[75] E. Chow,et al. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review , 2020, The Journal of Pediatrics.
[76] Kenan W. D. Stern,et al. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children , 2020, The Journal of Pediatrics.
[77] G. Di Sante,et al. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19. , 2020, The Pediatric infectious disease journal.
[78] K. Sullivan,et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.
[79] J. R. Contreras,et al. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain , 2020, Clinical Infectious Diseases.
[80] L. Henderson,et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1 , 2020, Arthritis & rheumatology.
[81] J. Chou,et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. , 2020, The Journal of clinical investigation.
[82] D. De Backer,et al. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report , 2020, Frontiers in Medicine.
[83] P. Palma,et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 , 2020, Cell.
[84] P. Davies,et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study , 2020, The Lancet Child & Adolescent Health.
[85] N. Rezaei,et al. Hyperinflammatory shock related to COVID‐19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran , 2020, Journal of paediatrics and child health.
[86] K. Wilson,et al. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, medRxiv.
[87] A. Šedivá,et al. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19 , 2020, Frontiers in Immunology.
[88] L. Titomanlio,et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis , 2020, The Lancet Child & Adolescent Health.
[89] U. Löbel,et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. , 2020, JAMA neurology.
[90] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[91] David R. Holtgrave,et al. Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.
[92] C. Murray,et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study , 2020, The Lancet Child & Adolescent Health.
[93] A. Bruckner,et al. Focus on "COVID Toes". , 2020, JAMA dermatology.
[94] D. Eytan,et al. PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AND HYPOCOMPLEMENTEMIA FOLLOWING SARS-COV-2 INFECTION. , 2020, The Pediatric infectious disease journal.
[95] Andrew R. Leach,et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.
[96] J. Tang,et al. COVID‐19 multisystem inflammatory syndrome in three teenagers with confirmed SARS‐CoV‐2 infection , 2020, Journal of medical virology.
[97] J. Yáñez,et al. Covid-19 in Peru: from supervised walks for children to the first case of Kawasaki-like syndrome , 2020, BMJ.
[98] K. Davidson,et al. Characteristics, Cardiac Involvement, and Outcomes of Multisystem Inflammatory Syndrome of Childhood Associated with severe acute respiratory syndrome coronavirus 2 Infection , 2020, The Journal of Pediatrics.
[99] B. Scholefield,et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital , 2020, Pediatric Cardiology.
[100] G. Carcelain,et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort , 2020, Annals of the Rheumatic Diseases.
[101] E. Blondiaux,et al. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series , 2020, Radiology.
[102] P. Zachariah,et al. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. , 2020, JAMA.
[103] B. McCrindle,et al. SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease? , 2020, JAMA.
[104] P. Davies,et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.
[105] U. Erenberk,et al. Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID‐19 in a 3‐year‐old girl , 2020, Dermatologic therapy.
[106] P. Zachariah,et al. Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases , 2020, Gastroenterology.
[107] Jérémie F. Cohen,et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study , 2020, BMJ.
[108] C. Delacourt,et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[109] J. Casanova,et al. The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? , 2020, Human Genetics.
[110] E. Mahé,et al. Erythema multiforme and Kawasaki disease associated with COVID‐19 infection in children , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[111] Yosikazu Nakamura,et al. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. , 2020, The Journal of pediatrics.
[112] P. Horby,et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.
[113] L. Bonnemains,et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic , 2020, Circulation.
[114] Angelo Mazza,et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.
[115] Russell M Viner,et al. Kawasaki-like disease: emerging complication during the COVID-19 pandemic , 2020, The Lancet.
[116] Jacques Fellay,et al. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection , 2020, Cell.
[117] E. Parodi,et al. SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children , 2020, Pediatrics.
[118] J. Orange,et al. The Growing Spectrum of Human Diseases Caused by InheritedCDC42 Mutations , 2020, Journal of Clinical Immunology.
[119] P. Theocharis,et al. Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.
[120] K. Brengel-Pesce,et al. Type I IFN immunoprofiling in COVID-19 patients , 2020, Journal of Allergy and Clinical Immunology.
[121] Yae-Jean Kim,et al. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic , 2020, Journal of Korean medical science.
[122] J. Casanova,et al. Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories. , 2020, Annual review of pathology.
[123] S. Maskatia,et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. , 2020, Hospital pediatrics.
[124] A. Rawat,et al. Immunogenetics of Kawasaki disease , 2020, Clinical Reviews in Allergy & Immunology.
[125] Mindy S Lo. A framework for understanding Kawasaki disease pathogenesis. , 2020, Clinical immunology.
[126] S. Canna,et al. Pediatric Hemophagocytic Lymphohistiocytosis (HLH). , 2020, Blood.
[127] K. Wylie,et al. A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease. , 2020, The Journal of infectious diseases.
[128] S. Tangye,et al. Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation , 2020, Journal of Clinical Immunology.
[129] S. Tangye,et al. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. , 2020, Blood.
[130] Ivan K. Chinn,et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function , 2019, The Journal of experimental medicine.
[131] Xiaochen Xie,et al. The T helper type 17/regulatory T cell imbalance was associated with Ras‐GTPase overexpression in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease , 2019, Immunology.
[132] D. Lewis,et al. Severe autoinflammation in four patients with C-terminal variants in CDC42 successfully treated with IL-1β inhibition. , 2019, The Journal of allergy and clinical immunology.
[133] P. Langford,et al. Kawasaki Disease: The Role of Immune Complexes Revisited , 2019, Front. Immunol..
[134] L. Jung,et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition , 2019, Pediatric Rheumatology.
[135] J. Burns,et al. How Should We Classify Kawasaki Disease? , 2018, Front. Immunol..
[136] J. Newburger,et al. Kawasaki Disease , 2018, Pediatrics in Review.
[137] Yosikazu Nakamura,et al. Kawasaki disease: epidemiology and the lessons from it , 2017, International journal of rheumatic diseases.
[138] M. Stringer. Acute appendicitis , 2017, Journal of paediatrics and child health.
[139] C. Wouters,et al. How Viruses Contribute to the Pathogenesis of Hemophagocytic Lymphohistiocytosis , 2017, Front. Immunol..
[140] Todd A. Johnson,et al. A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease , 2017, Journal of Human Genetics.
[141] M. Levin,et al. Dissecting Kawasaki disease: a state-of-the-art review , 2017, European Journal of Pediatrics.
[142] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[143] J. Newburger,et al. Kawasaki Disease. , 2013, Journal of the American College of Cardiology.
[144] G. Hajishengallis,et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates , 2015, Science Translational Medicine.
[145] P. Lebon,et al. Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study". , 2014, Pathologie-biologie.
[146] Yusuke Nakamura,et al. A genome-wide association study identifies three new risk loci for Kawasaki disease , 2012, Nature Genetics.
[147] Fuu-Jen Tsai,et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis , 2012, Nature Genetics.
[148] G. Janka,et al. Familial and acquired hemophagocytic lymphohistiocytosis. , 2012, Annual review of medicine.
[149] Tien Yin Wong,et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease , 2011, Nature Genetics.
[150] Y. Zu,et al. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease , 2010, Clinical and experimental immunology.
[151] O. Ramilo,et al. CONCOMITANT RESPIRATORY VIRAL INFECTIONS IN CHILDREN WITH KAWASAKI DISEASE , 2010, The Pediatric infectious disease journal.
[152] R. Holman,et al. Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007 , 2010, The Pediatric infectious disease journal.
[153] R. Klar,et al. Kawasaki disease lacks association with human coronavirus NL63 and human bocavirus. , 2009, The Pediatric infectious disease journal.
[154] Yoshihiro Onouchi,et al. Molecular Genetics of Kawasaki Disease , 2009, Pediatric Research.
[155] J. Kanegaye,et al. Recognition of a Kawasaki Disease Shock Syndrome , 2009, Pediatrics.
[156] P. Bruhns,et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. , 2009, Blood.
[157] Yusuke Nakamura,et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.
[158] K. Holmes,et al. Blinded Case‐Control Study of the Relationship between Human Coronavirus NL63 and Kawasaki Syndrome , 2006, The Journal of infectious diseases.
[159] J. Burns,et al. Human Coronavirus NL63 Is Not Detected in the Respiratory Tracts of Children with Acute Kawasaki Disease , 2005, The Journal of infectious diseases.
[160] J. Casanova,et al. Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[161] K. Gauvreau,et al. Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis , 2005, Pediatrics.
[162] E. Shapiro,et al. Association between a Novel Human Coronavirus and Kawasaki Disease , 2005, The Journal of infectious diseases.
[163] J. Burns,et al. Kawasaki syndrome , 2004, The Lancet.
[164] L. Haines,et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. , 2003, The Cochrane database of systematic reviews.
[165] H. Jäck,et al. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. , 1997, Journal of Immunology.
[166] O. Teixeira,et al. Long-term consequences of Kawasaki disease. , 1997, Circulation.
[167] K Hashino,et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.
[168] G. Lombard,et al. Pediatric Intensive Care Unit , 2009 .
[169] H. Yanagawa,et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.
[170] T. Kawasaki,et al. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].